Results 51 to 60 of about 483,790 (291)

Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia [PDF]

Emerging Infectious Diseases, 2020
Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical ...
Katherine Laiton‐Donato, C. Julian Villabona-Arenas, José A. Usme-Ciro, Carlos Franco-Muñoz, Diego A. Álvarez-Díaz, Liz Stephany Villabona-Arenas, Susy Echeverría-Londoño, Zulma M. Cucunubá, Nicolás D. Franco‐Sierra, Astrid Carolina Flórez, Carolina Ferro, Nadim J. Ajami, Diana Marcela Walteros, Franklin Prieto, Carlos Andrés Durán, Martha L. Ospina-Martinez, Marcela Mercado   +16 more
openaire   +6 more sources

Clinical Trials of Repurposed Antivirals for SARS-CoV-2 [PDF]

, 2020
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted the repurposing of drugs on the basis of promising in vitro and therapeutic results with other human coronavirus ...
Martinez, Miguel Angel
core   +1 more source

Association of ABO blood group with susceptibility to SARS-CoV-2 infection in Rupandehi district of Nepal

SAGE Open Medicine, 2022
Objectives: Recent studies after the outbreak of coronavirus disease 2019 have shown an association of the ABO blood group to the susceptibility of severe acute respiratory syndrome coronavirus 2 infection.
Sanyukta Gurung, Narayan Bahadur Mahotra, Lava Shrestha, Aakash Sherpali, Surya Prakash Joshi, Gambhir Shrestha, Shailesh Shrestha, Aman Shakya, Manoj Kandel   +8 more
doaj   +1 more source

Severe acute respiratory syndrome coronavirus 2: a canary in the coal mine for public safety net hospitalsAJOG MFM at a Glance

AJOG Global Reports, 2021
BACKGROUND: The coronavirus disease 2019 pandemic has exposed disproportionate health inequities among underserved populations, including refugees. Public safety net healthcare systems play a critical role in facilitating access to care for refugees and ...
Crista E. Johnson-Agbakwu, MD, MSc, Cortney M. Eakin, MD, Celeste V. Bailey, MD, Shelly Sood, MD, Nyima Ali, MD, Pooja Doehrman, MD, MPH, Bikash Bhattarai, PhD, Linda Chambliss, MD, Dean V. Coonrod, MD, MPH   +8 more
doaj   +1 more source

A Case Report of Coronavirus Disease 2019 Presenting with Tremors and Gait Disturbance [PDF]

, 2020
Introduction: Neurologic symptoms present as significant complications of coronavirus disease 2019 (COVID-19) infection. This report describes a novel manifestation of tremors triggered by severe acute respiratory syndrome coronavirus 2 infection.Case ...
Berman, Adam, Davis, Frederick, D’Angelo, John, Klein, Sharon, Koti, Shruti, Kwon, Nancy   +5 more
core   +2 more sources

Myopericarditis caused by severe acute respiratory syndrome coronavirus 2

Clinical and Experimental Emergency Medicine, 2020
A 25-year-old man presented to the emergency department with acute-onset chest pain and shortness of breath. A physical examination revealed coarse crackles in the both lower lungs. Consolidation and ground-glass opacities suggesting viral infection were detected in the right lower lobe on chest computed tomography.
Kose, Ataman, Ozkan, Bugra, Ozturan, İBRAHİM ULAŞ, Kose, Beril   +3 more
openaire   +5 more sources

Heat inactivation of the severe acute respiratory syndrome coronavirus 2 [PDF]

Journal of Biosafety and Biosecurity, 2020
AbstractSupernatants of cells infected with SARS-CoV-2, nasopharyngeal and sera samples containing SARS-CoV-2 were submitted to heat inactivation for various periods of time, ranging from 30 seconds to 60 minutes. Our results showed that SARS-CoV-2 could be inactivated in less than 30 minutes, 15 minutes and 3 minutes at 56°C, 65°C and 95°C ...
Batéjat, Christophe, Grassin, Quentin, Manuguerra, Jean-Claude, Leclercq, India   +3 more
openaire   +3 more sources

Severe acute respiratory syndrome coronavirus 2 seroprevalence among patients with pulmonary tuberculosis [PDF]

, 2023
Objective: The objective of this study was to estimate the seroprevalence of severe acute respiratory syndrome coronavirus 2 antibodies in patients with tuberculosis.
Barbosa, Márcia Silva, Dias, Natan José Dutra, Pereira, Giovana Rodrigues, Silva, Denise Rossato, Silva, Maiana Silva da   +4 more
core  

Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview [PDF]

Head & Neck, 2020
AbstractThe novel coronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and was declared a pandemic in March 2020. A plethora of respiratory sampling methods for SARS‐CoV‐2 viral detection has been used and in the current evolving situation, there is no international consensus on the recommended method ...
See, Anna, Toh, Song Tar
openaire   +2 more sources

Reduced frequency of migraine attacks following coronavirus disease 2019: a case report

Journal of Medical Case Reports, 2023
Background Severe acute respiratory syndrome coronavirus 2 is a virus affecting different organs and causing a wide variety and severity of symptoms. Headache as well as loss of smell and taste are the most frequently reported neurological manifestations
Roland Houben
doaj   +1 more source